RAPT
RAPT Therapeutics Inc

2,665
Mkt Cap
$1.6B
Volume
5.14M
52W High
$57.86
52W Low
$5.67
PE Ratio
-5.21
RAPT Fundamentals
Price
$57.77
Prev Close
$57.69
Open
$57.71
50D MA
$40.46
Beta
1.64
Avg. Volume
2.8M
EPS (Annual)
-$25.49
P/B
6.40
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Rapt Therapeutics (NASDAQ:RAPT) Sees Large Volume Increase - Here's What Happened
Rapt Therapeutics (NASDAQ:RAPT) Sees Large Volume Increase - Still a Buy...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Rapt Therapeutics (NASDAQ:RAPT) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Rapt Therapeutics (NASDAQ:RAPT - Get Free Report) have been given a consensus recommendation of "Hold" by the thirteen analysts that are presently covering the company, MarketBeat.com...
MarketBeat·2d ago
News Placeholder
Halper Sadeh LLC is Investigating Whether NWE, DHIL, RAPT are Obtaining Fair Prices for its Shareholders
Halper Sadeh LLC is Investigating Whether NWE, DHIL, RAPT are Obtaining Fair Prices for its Shareholders Halper Sadeh LLC is Investigating Whether NWE, DHIL, RAPT are Obtaining Fair Prices for its...
PR Newswire·3d ago
News Placeholder
RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of RAPT Therapeutics, Inc. (NasdaqGM: RAPT) to GSK...
Business Wire·4d ago
News Placeholder
Best Small Cap Stocks To Watch Now - February 5th
Inflection Point Acquisition Corp. II, Rapt Therapeutics, Direxion Daily TSLA Bear 1X Shares, Direxion Daily PLTR Bear 1X Shares, Direxion Daily GOOGL Bull 2X Shares, Spring Valley Acquisition, and...
MarketBeat·4d ago
News Placeholder
Rapt Therapeutics (NASDAQ:RAPT) Hits New 12-Month High - Here's Why
Rapt Therapeutics (NASDAQ:RAPT) Reaches New 52-Week High - Still a Buy...
MarketBeat·5d ago
News Placeholder
Rapt Therapeutics (NASDAQ:RAPT) Reaches New 12-Month High - Still a Buy?
Rapt Therapeutics (NASDAQ:RAPT) Sets New 12-Month High - Here's Why...
MarketBeat·11d ago
News Placeholder
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their...
PR Newswire·12d ago
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA...
PR Newswire·13d ago
News Placeholder
RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of RAPT Therapeutics, Inc. (NasdaqGM: RAPT) to GSK...
Business Wire·19d ago
<
1
2
...
>

Latest RAPT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.